Skip to main content
Skip to content
Case File
kaggle-ho-024106House Oversight

Methodology for Calculating Synthetic Net Returns for Sprout Healthcare Technology Portfolios

Methodology for Calculating Synthetic Net Returns for Sprout Healthcare Technology Portfolios The passage details internal fund performance calculations for Sprout Healthcare funds. It contains no references to high‑profile individuals, government agencies, or suspicious financial flows beyond standard venture‑capital metrics, offering minimal investigative leads. Key insights: Synthetic net returns are estimated as if investments were in a standalone healthcare VC fund.; Assumes 2% quarterly management fees and 25% carried interest.; Example: Sprout IX shows $1.075B distributed to LPs and $50M remaining value.

Date
Unknown
Source
House Oversight
Reference
kaggle-ho-024106
Pages
1
Persons
0
Integrity
No Hash Available

Summary

Methodology for Calculating Synthetic Net Returns for Sprout Healthcare Technology Portfolios The passage details internal fund performance calculations for Sprout Healthcare funds. It contains no references to high‑profile individuals, government agencies, or suspicious financial flows beyond standard venture‑capital metrics, offering minimal investigative leads. Key insights: Synthetic net returns are estimated as if investments were in a standalone healthcare VC fund.; Assumes 2% quarterly management fees and 25% carried interest.; Example: Sprout IX shows $1.075B distributed to LPs and $50M remaining value.

Tags

kagglehouse-oversightventure-capitalfund-accountinghealthcare-technologyfinancial-methodology

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.